StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical gross margin

Gross margin is gross profit as a percentage of revenue.

Impact BioMedical's gross margin for the twelve months ending Dec 31, 2025 was -1225.0%. For fiscal 2025 it was -1225.0%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1225.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202666.7%–
Q4 FY2025Dec 31, 2025-5928.6%–
Q3 FY2025Sep 30, 202594.4%–
Q2 FY2025Jun 30, 202585.7%–

More Impact BioMedical figures

See a number that looks wrong?